Home NuSight Medical

NuSight Medical

    NuSight Medical Announces Issuance of U.S. Patent Covering the NuLids System® for Treating Dry Eye Disease

    U.S. Patent No. 10,314,763 covers the use of the NuLids System treatment for the treatment of dry eye/ocular surface disease, blepharitis and related conditions. “The patent protects our entire NuLids system – the device and methods for its use, the disposable soft-tips, and product safety features” said Robert Foster, CEO of NuSight Medical.

    RECENT COMMENTS